How is the EY-Parthenon Life Sciences practice?
2
For those who have escaped to industry, curious how WLB differs between consulting and some of the more high-visibility functions like BD/CorpDev at a larger biotech with a reputation for intensity like a BridgeBio or similar? Versus say a supporting role in insights or forecasting? I understand a lot is manager and company dependent but curious the range of folks' experience. Thanks in advance
I've never heard of them
Going downhill
If you want to do deals or PE, it’s good. Strategy is horrible. They only really do peripherals like CRO, CDMO, etc. no true pharma strategy and also a ton of people have left the LS strategy practice in the past few months.